SCHEMBL9562820

SCHEMBL9562820

NCCCOP(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28991670 0.92
SCHEMBL5078489 0.89 DNM1 (0.42)
SCHEMBL1530922 0.89 DNM1 (0.42)
SCHEMBL10050128 0.81
SCHEMBL11655457 0.81
SCHEMBL13496566 0.81
Tetradecylamine SCHEMBL28102760 0.79 DNM1 (0.54)
SCHEMBL2337154 0.78
SCHEMBL28693934 0.77
Ammonia Solution, Strong SCHEMBL9441914 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101001612-A Controlled release dosage forms for gamma aminobutyric acid receptor agonists IMPAX LABORATORIES INC (US) 2007-07-18 CN disclosed
CN-1596141-A Conjugated antipsychotics and uses thereof RAMOT AT TEL AVIA UNIVERSITY L (IL) 2005-03-16 CN disclosed
EP-0533352-A2 Gaba receptor agonists to treat bladder instability LYNXVALE LIMITED (GB) 1993-03-24 EP disclosed